Breaking News Instant updates and real-time market news.

ZURVY

Zurich Insurance

$0.00 /

+ (+0.00%)

05:31
12/04/19
12/04
05:31
12/04/19
05:31

Zurich Insurance upgraded to Overweight from Equal Weight at Barclays

Barclays analyst Claudia Gaspari upgraded Zurich Insurance to Overweight from Equal Weight with a CHF 424 price target.

ZURVY Zurich Insurance
$0.00 /

+ (+0.00%)

11/20/19 Jefferies
Zurich Insurance downgraded to Hold from Buy at Jefferies
08/20/19 Jefferies
Zurich Insurance upgraded to Buy from Hold at Jefferies
06/20/19 JPMorgan
Zurich Insurance upgraded to Overweight from Neutral at JPMorgan
05/31/19 HSBC
Zurich Insurance downgraded to Hold from Buy at HSBC

TODAY'S FREE FLY STORIES

Upgrade
AAR Corp. upgraded to Buy from Hold at Truist » 07:03
12/01/20
12/01
07:03
12/01/20
07:03
AIR

AAR Corp.

$28.25 /

-1.2 (-4.07%)

Truist analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AIR AAR Corp.
$28.25 /

-1.2 (-4.07%)

AIR AAR Corp.
$28.25 /

-1.2 (-4.07%)

07/15/20 SunTrust
SunTrust downgrades select commercial aviation supply stocks
07/15/20 SunTrust
AAR Corp. downgraded to Hold from Buy at SunTrust
06/30/20 Canaccord
AAR Corp. upcoming results focused on second half recovery, says Canaccord
03/18/20 Canaccord
AAR Corp. price target lowered to $25 from $55 at Canaccord
AIR AAR Corp.
$28.25 /

-1.2 (-4.07%)

AIR AAR Corp.
$28.25 /

-1.2 (-4.07%)

Hot Stocks
Timken acquires assets of Aurora Bearing for undisclosed amount » 07:02
12/01/20
12/01
07:02
12/01/20
07:02
TKR

Timken

$73.43 /

-1.125 (-1.51%)

The Timken has acquired…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TKR Timken
$73.43 /

-1.125 (-1.51%)

TKR Timken
$73.43 /

-1.125 (-1.51%)

11/13/20 KeyBanc
Timken price target raised to $85 from $68 at KeyBanc
11/02/20 Citi
Timken initiated with a Buy at Citi
01/07/20 KeyBanc
NN, Inc. could 'benefit the most' from strategic divestiture, says KeyBanc
01/07/20 BofA
BofA double upgrades Timken to Buy, sees potential upside to $68
TKR Timken
$73.43 /

-1.125 (-1.51%)

TKR Timken
$73.43 /

-1.125 (-1.51%)

Hot Stocks
Agios Pharmaceuticals says Phase 3 ACTIVATE trial achieved primary endpoint » 07:02
12/01/20
12/01
07:02
12/01/20
07:02
AGIO

Agios Pharmaceuticals

$46.32 /

+1.73 (+3.88%)

Agios Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGIO Agios Pharmaceuticals
$46.32 /

+1.73 (+3.88%)

AGIO Agios Pharmaceuticals
$46.32 /

+1.73 (+3.88%)

11/20/20 Barclays
Agios Pharmaceuticals price target raised to $50 from $46 at Barclays
11/19/20 Piper Sandler
Piper continues to like setup for Agios Pharmaceuticals shares into ASH
11/19/20 Cantor Fitzgerald
Agios Pharmaceuticals price target raised to $79 from $68 at Cantor Fitzgerald
10/22/20 Barclays
Agios upgraded to Overweight with $46 target at Barclays
AGIO Agios Pharmaceuticals
$46.32 /

+1.73 (+3.88%)

AGIO Agios Pharmaceuticals
$46.32 /

+1.73 (+3.88%)

Hot Stocks
AstraZeneca reports Crestor to be divested to Grunenthal in Europe » 07:00
12/01/20
12/01
07:00
12/01/20
07:00
AZN

AstraZeneca

$52.94 /

+0.36 (+0.68%)

AstraZeneca has agreed to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AZN AstraZeneca
$52.94 /

+0.36 (+0.68%)

AZN AstraZeneca
$52.94 /

+0.36 (+0.68%)

11/30/20 UBS
AstraZeneca upgraded to Neutral from Sell at UBS
11/27/20 Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
11/27/20 Citi
Citi opens 'positive catalyst watch' on AstraZeneca after vaccine selloff
11/24/20 Piper Sandler
Astra vaccine results 'de-risking' for Altimmune, says Piper Sandler
AZN AstraZeneca
$52.94 /

+0.36 (+0.68%)

AZN AstraZeneca
$52.94 /

+0.36 (+0.68%)

AZN AstraZeneca
$52.94 /

+0.36 (+0.68%)

AZN AstraZeneca
$52.94 /

+0.36 (+0.68%)

Recommendations
Marvell price target raised to $54 from $50 at Susquehanna » 06:59
12/01/20
12/01
06:59
12/01/20
06:59
MRVL

Marvell

$46.28 /

+1.16 (+2.57%)

Susquehanna analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$46.28 /

+1.16 (+2.57%)

MRVL Marvell
$46.28 /

+1.16 (+2.57%)

11/30/20 B. Riley Securities
Marvell price target raised to $55 from $48 at B. Riley Securities
11/19/20 Citi
Citi moves Lam Research, Marvell to top picks in Semi Equipment
11/04/20 KeyBanc
KeyBanc lays out possible M&A candidates as semi consolidation heats ups
10/30/20 Needham
Inphi price target raised to $175 from $145 at Needham
MRVL Marvell
$46.28 /

+1.16 (+2.57%)

MRVL Marvell
$46.28 /

+1.16 (+2.57%)

MRVL Marvell
$46.28 /

+1.16 (+2.57%)

MRVL Marvell
$46.28 /

+1.16 (+2.57%)

Hot Stocks
Church & Dwight completes acquisition of Zicam brand for $530M » 06:57
12/01/20
12/01
06:57
12/01/20
06:57
CHD

Church & Dwight

$87.83 /

+1.54 (+1.78%)

Church & Dwight has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHD Church & Dwight
$87.83 /

+1.54 (+1.78%)

08/03/20 Truist
Church & Dwight price target raised to $105 from $90 at Truist
08/03/20 RBC Capital
Church & Dwight price target raised to $90 from $65 at RBC Capital
08/03/20 Deutsche Bank
Church & Dwight price target raised to $89 from $78 at Deutsche Bank
07/24/20 Oppenheimer
Church & Dwight price target raised to $100 from $88 at Oppenheimer
CHD Church & Dwight
$87.83 /

+1.54 (+1.78%)

CHD Church & Dwight
$87.83 /

+1.54 (+1.78%)

CHD Church & Dwight
$87.83 /

+1.54 (+1.78%)

Initiation
Sabesp initiated with a Buy at Citi » 06:56
12/01/20
12/01
06:56
12/01/20
06:56
SBS

Sabesp

$8.30 /

-0.065 (-0.78%)

Citi analyst Antonio…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBS Sabesp
$8.30 /

-0.065 (-0.78%)

04/06/20 JPMorgan
Sabesp downgraded to Neutral from Overweight at JPMorgan
12/02/19 JPMorgan
Sabesp upgraded to Overweight from Neutral at JPMorgan
Upgrade
Sonova upgraded to Buy from Hold at Jefferies » 06:55
12/01/20
12/01
06:55
12/01/20
06:55
SONVY

Sonova

$0.00 /

+ (+0.00%)

Jefferies analyst Kit Lee…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SONVY Sonova
$0.00 /

+ (+0.00%)

11/24/20 JPMorgan
Sonova price target raised to CHF 226 from CHF 212 at JPMorgan
11/23/20 Berenberg
Sonova price target raised to CHF 215 from CHF 210 at Berenberg
11/17/20 Credit Suisse
Sonova price target raised to CHF 270 from CHF 265 at Credit Suisse
11/17/20 UBS
Sonova price target raised to CHF 253 from CHF 241 at UBS
Recommendations
GM no longer wants to be tied to Nikola's longer term outlook, says Deutsche » 06:53
12/01/20
12/01
06:53
12/01/20
06:53
NKLA

Nikola

$20.33 /

-7.58 (-27.16%)

, GM

General Motors

$43.85 /

-1.17 (-2.60%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKLA Nikola
$20.33 /

-7.58 (-27.16%)

GM General Motors
$43.85 /

-1.17 (-2.60%)

NKLA Nikola
$20.33 /

-7.58 (-27.16%)

11/30/20 Cowen
Nikola deal with GM being mischaracterized, is a positive, says Cowen
11/30/20 JPMorgan
Nikola pullback could be a good buying opportunity, says JPMorgan
11/30/20 Wedbush
Wedbush keeps Underperform rating on Nikola as revised GM deal disappoints
11/30/20 Deutsche Bank
Nikola to see 'large stock volatility' this week, says Deutsche Bank
GM General Motors
$43.85 /

-1.17 (-2.60%)

11/30/20 Cowen
Nikola deal with GM being mischaracterized, is a positive, says Cowen
11/30/20 JPMorgan
Nikola pullback could be a good buying opportunity, says JPMorgan
11/30/20 Wedbush
Wedbush keeps Underperform rating on Nikola as revised GM deal disappoints
11/30/20 Deutsche Bank
Nikola to see 'large stock volatility' this week, says Deutsche Bank
NKLA Nikola
$20.33 /

-7.58 (-27.16%)

GM General Motors
$43.85 /

-1.17 (-2.60%)

NKLA Nikola
$20.33 /

-7.58 (-27.16%)

GM General Motors
$43.85 /

-1.17 (-2.60%)

NKLA Nikola
$20.33 /

-7.58 (-27.16%)

GM General Motors
$43.85 /

-1.17 (-2.60%)

NKLA Nikola
$20.33 /

-7.58 (-27.16%)

GM General Motors
$43.85 /

-1.17 (-2.60%)

Initiation
Link Mobility initiated with a Buy at Jefferies » 06:52
12/01/20
12/01
06:52
12/01/20
06:52
LMGHF

Link Mobility

$0.00 /

+ (+0.00%)

Jefferies analyst Julian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Apellis price target raised to $66 from $57 at BMO Capital » 06:51
12/01/20
12/01
06:51
12/01/20
06:51
APLS

Apellis

$47.14 /

-0.09 (-0.19%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APLS Apellis
$47.14 /

-0.09 (-0.19%)

APLS Apellis
$47.14 /

-0.09 (-0.19%)

11/23/20 Citi
Apellis price target raised to $67 from $53 at Citi
11/19/20 Needham
Apellis initiated with a Buy at Needham
09/01/20
Fly Intel: Top five analyst initiations
08/31/20 Stifel
Apellis initiated with a Buy at Stifel
APLS Apellis
$47.14 /

-0.09 (-0.19%)

  • 09
    Jan
Recommendations
PPG price target raised to $165 from $155 at Deutsche Bank » 06:50
12/01/20
12/01
06:50
12/01/20
06:50
PPG

PPG

$146.79 /

-0.87 (-0.59%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PPG PPG
$146.79 /

-0.87 (-0.59%)

PPG PPG
$146.79 /

-0.87 (-0.59%)

06:29 Today Barclays
PPG price target raised to $155 from $151 at Barclays
10/21/20 Wells Fargo
PPG price target raised to $155 from $146 at Wells Fargo
10/21/20 Deutsche Bank
PPG price target raised to $155 from $150 at Deutsche Bank
10/20/20 Morgan Stanley
PPG price target raised to $140 from $120 at Morgan Stanley
PPG PPG
$146.79 /

-0.87 (-0.59%)

PPG PPG
$146.79 /

-0.87 (-0.59%)

PPG PPG
$146.79 /

-0.87 (-0.59%)

Upgrade
AA PLC upgraded to Hold from Underperform at Jefferies » 06:49
12/01/20
12/01
06:49
12/01/20
06:49
AATDF

AA PLC

$0.00 /

+ (+0.00%)

Jefferies analyst Will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AATDF AA PLC
$0.00 /

+ (+0.00%)

10/01/20 Berenberg
AA PLC upgraded to Hold from Sell at Berenberg
03/16/20 Jefferies
AA PLC price target lowered to 5 GBp from 55 GBp at Jefferies
Initiation
MP Materials initiated with a Buy at Deutsche Bank » 06:49
12/01/20
12/01
06:49
12/01/20
06:49
MP

MP Materials

$21.43 /

-0.46 (-2.10%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MP MP Materials
$21.43 /

-0.46 (-2.10%)

Recommendations
Sage Therapeutics price target lowered to $93 from $100 at Citi » 06:47
12/01/20
12/01
06:47
12/01/20
06:47
SAGE

Sage Therapeutics

$74.09 /

-1.5 (-1.98%)

, BIIB

Biogen

$240.36 /

-3.61 (-1.48%)

Citi analyst Neena…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$74.09 /

-1.5 (-1.98%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

SAGE Sage Therapeutics
$74.09 /

-1.5 (-1.98%)

06:47 Today RBC Capital
Biogen price target raised to $256 from $249 at RBC Capital
06:07 Today H.C. Wainwright
Sage Therapeutics price target lowered to $74 from $81 at H.C. Wainwright
11/30/20 Raymond James
Sage Therapeutics downgraded to Market Perform from Outperform at Raymond James
11/30/20 RBC Capital
Sage Therapeutics price target lowered to $83 from $86 at RBC Capital
BIIB Biogen
$240.36 /

-3.61 (-1.48%)

06:47 Today RBC Capital
Biogen price target raised to $256 from $249 at RBC Capital
06:07 Today H.C. Wainwright
Sage Therapeutics price target lowered to $74 from $81 at H.C. Wainwright
11/30/20 Piper Sandler
Piper Sandler likes Sage deal, keeps Neutral rating on Biogen
11/27/20 Stifel
Stifel says license deal 'good' for Biogen, takes some upside off table for Sage
SAGE Sage Therapeutics
$74.09 /

-1.5 (-1.98%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

SAGE Sage Therapeutics
$74.09 /

-1.5 (-1.98%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

Recommendations
Biogen price target raised to $256 from $249 at RBC Capital » 06:47
12/01/20
12/01
06:47
12/01/20
06:47
BIIB

Biogen

$240.36 /

-3.61 (-1.48%)

, SAGE

Sage Therapeutics

$74.09 /

-1.5 (-1.98%)

RBC Capital analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIIB Biogen
$240.36 /

-3.61 (-1.48%)

SAGE Sage Therapeutics
$74.09 /

-1.5 (-1.98%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

06:07 Today H.C. Wainwright
Sage Therapeutics price target lowered to $74 from $81 at H.C. Wainwright
11/30/20 Piper Sandler
Piper Sandler likes Sage deal, keeps Neutral rating on Biogen
11/27/20 Stifel
Stifel says license deal 'good' for Biogen, takes some upside off table for Sage
11/10/20 Truist
Truist raises Biogen price target to $443, views aducanumab approval as 'likely'
SAGE Sage Therapeutics
$74.09 /

-1.5 (-1.98%)

06:07 Today H.C. Wainwright
Sage Therapeutics price target lowered to $74 from $81 at H.C. Wainwright
11/30/20 Raymond James
Sage Therapeutics downgraded to Market Perform from Outperform at Raymond James
11/30/20 RBC Capital
Sage Therapeutics price target lowered to $83 from $86 at RBC Capital
11/30/20 Piper Sandler
Piper Sandler likes Sage deal, keeps Neutral rating on Biogen
BIIB Biogen
$240.36 /

-3.61 (-1.48%)

SAGE Sage Therapeutics
$74.09 /

-1.5 (-1.98%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

SAGE Sage Therapeutics
$74.09 /

-1.5 (-1.98%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

BIIB Biogen
$240.36 /

-3.61 (-1.48%)

Downgrade
AB InBev downgraded to Hold from Buy at Deutsche Bank » 06:46
12/01/20
12/01
06:46
12/01/20
06:46
BUD

AB InBev

$66.67 /

-1.68 (-2.46%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BUD AB InBev
$66.67 /

-1.68 (-2.46%)

BUD AB InBev
$66.67 /

-1.68 (-2.46%)

11/27/20 Morgan Stanley
AB InBev price target raised to EUR 61 from EUR 44 at Morgan Stanley
11/12/20 Redburn
AB InBev downgraded to Neutral from Buy at Redburn
11/02/20 Deutsche Bank
AB InBev price target raised to EUR 59 from EUR 58 at Deutsche Bank
10/30/20 Barclays
AB InBev price target raised to EUR 54 from EUR 51 at Barclays
BUD AB InBev
$66.67 /

-1.68 (-2.46%)

BUD AB InBev
$66.67 /

-1.68 (-2.46%)

BUD AB InBev
$66.67 /

-1.68 (-2.46%)

BUD AB InBev
$66.67 /

-1.68 (-2.46%)

Upgrade
Pernod Ricard upgraded to Buy from Hold at Deutsche Bank » 06:45
12/01/20
12/01
06:45
12/01/20
06:45
PDRDY

Pernod Ricard

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PDRDY Pernod Ricard
$0.00 /

+ (+0.00%)

11/27/20 Morgan Stanley
Pernod Ricard upgraded to Overweight from Equal Weight at Morgan Stanley
11/25/20 Credit Suisse
Pernod Ricard downgraded to Neutral from Outperform at Credit Suisse
11/25/20 Credit Suisse
Pernod Ricard downgraded to Neutral from Outperform at Credit Suisse
10/23/20 Barclays
Pernod Ricard price target lowered to EUR 168 from EUR 173 at Barclays
Upgrade
Diageo upgraded to Buy from Hold at Deutsche Bank » 06:45
12/01/20
12/01
06:45
12/01/20
06:45
DEO

Diageo

$155.05 /

-1.72 (-1.10%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DEO Diageo
$155.05 /

-1.72 (-1.10%)

DEO Diageo
$155.05 /

-1.72 (-1.10%)

11/27/20 Morgan Stanley
Diageo upgraded to Overweight from Equal Weight at Morgan Stanley
11/25/20 Credit Suisse
Diageo upgraded to Outperform from Neutral at Credit Suisse
11/25/20 Credit Suisse
Diageo upgraded to Outperform from Neutral at Credit Suisse
11/09/20 Barclays
Diageo price target raised to 3,040 GBp from 2,960 GBp at Barclays
DEO Diageo
$155.05 /

-1.72 (-1.10%)

DEO Diageo
$155.05 /

-1.72 (-1.10%)

Downgrade
CoreLogic downgraded to Hold from Buy at Truist » 06:45
12/01/20
12/01
06:45
12/01/20
06:45
CLGX

CoreLogic

$77.51 /

-0.225 (-0.29%)

Truist analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$77.51 /

-0.225 (-0.29%)

CLGX CoreLogic
$77.51 /

-0.225 (-0.29%)

10/28/20 Truist
CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist
09/22/20 Truist
CoreLogic increasingly likely to see other financial suitors, says Truist
07/24/20
Fly Intel: Top five analyst downgrades
07/24/20 Stephens
Stephens sees limited further upside for CoreLogic shares, cuts to Equal Weight
CLGX CoreLogic
$77.51 /

-0.225 (-0.29%)

CLGX CoreLogic
$77.51 /

-0.225 (-0.29%)

CLGX CoreLogic
$77.51 /

-0.225 (-0.29%)

Upgrade
Verisk Analytics upgraded to Buy from Hold at Truist » 06:44
12/01/20
12/01
06:44
12/01/20
06:44
VRSK

Verisk Analytics

$198.16 /

+0.12 (+0.06%)

Truist analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRSK Verisk Analytics
$198.16 /

+0.12 (+0.06%)

VRSK Verisk Analytics
$198.16 /

+0.12 (+0.06%)

11/09/20 BMO Capital
Verisk Analytics price target raised to $196 from $181 at BMO Capital
11/06/20 Barclays
Verisk Analytics price target raised to $220 from $210 at Barclays
11/05/20 Deutsche Bank
Verisk Analytics price target raised to $192 from $183 at Deutsche Bank
08/06/20 Barclays
Verisk Analytics price target raised to $210 from $165 at Barclays
VRSK Verisk Analytics
$198.16 /

+0.12 (+0.06%)

Downgrade
IHS Markit downgraded to Hold from Buy at Truist » 06:43
12/01/20
12/01
06:43
12/01/20
06:43
INFO

IHS Markit

$99.37 /

+6.85 (+7.40%)

Truist analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INFO IHS Markit
$99.37 /

+6.85 (+7.40%)

INFO IHS Markit
$99.37 /

+6.85 (+7.40%)

06:36 Today RBC Capital
IHS Markit downgraded to Sector Perform from Outperform at RBC Capital
11/30/20 Oppenheimer
S&P Global, IHS Markit would benefit shareholders, says Oppenheimer
09/30/20 Truist
IHS Markit price target raised to $90 from $87 at Truist
09/30/20 JPMorgan
IHS Markit price target raised to $79 from $75 at JPMorgan
INFO IHS Markit
$99.37 /

+6.85 (+7.40%)

INFO IHS Markit
$99.37 /

+6.85 (+7.40%)

INFO IHS Markit
$99.37 /

+6.85 (+7.40%)

Recommendations
Adient price target raised to $38 from $24 at RBC Capital » 06:43
12/01/20
12/01
06:43
12/01/20
06:43
ADNT

Adient

/

+

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADNT Adient
/

+

ADNT Adient
/

+

11/17/20 BofA
Adient, Aptiv get double downgrades as BofA reshuffles auto industry ratings
11/17/20 BofA
Adient downgraded to Underperform from Buy at BofA
10/22/20 JPMorgan
Adient price target raised to $17 from $13 at JPMorgan
10/22/20 Barclays
Adient price target raised to $27 from $23 at Barclays
ADNT Adient
/

+

Initiation
Expedia initiated with a Market Perform at Bernstein » 06:43
12/01/20
12/01
06:43
12/01/20
06:43
EXPE

Expedia

/

+

, BKNG

Booking Holdings

$2,028.75 /

-21.84 (-1.07%)

Bernstein analyst Richard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EXPE Expedia
/

+

BKNG Booking Holdings
$2,028.75 /

-21.84 (-1.07%)

EXPE Expedia
/

+

06:25 Today Barclays
Expedia price target raised to $140 from $120 at Barclays
11/30/20 Bernstein
Expedia initiated with a Market Perform at Bernstein
11/30/20 Morgan Stanley
Expedia price target raised to $135 from $88 at Morgan Stanley
11/05/20 BTIG
Expedia price target raised to $145 from $120 at BTIG
BKNG Booking Holdings
$2,028.75 /

-21.84 (-1.07%)

06:39 Today Bernstein
Booking Holdings initiated with an Underperform at Bernstein
06:25 Today Barclays
Booking Holdings price target raised to $2,290 from $1,960 at Barclays
11/30/20 Bernstein
Booking Holdings initiated with an Underperform at Bernstein
11/30/20 Morgan Stanley
Booking Holdings price target raised to $2,250 from $2,085 at Morgan Stanley
EXPE Expedia
/

+

BKNG Booking Holdings
$2,028.75 /

-21.84 (-1.07%)

EXPE Expedia
/

+

BKNG Booking Holdings
$2,028.75 /

-21.84 (-1.07%)

EXPE Expedia
/

+

BKNG Booking Holdings
$2,028.75 /

-21.84 (-1.07%)

EXPE Expedia
/

+

BKNG Booking Holdings
$2,028.75 /

-21.84 (-1.07%)

Hot Stocks
Lexaria Bioscience says DehydraTECH improved delivery in study animals » 06:43
12/01/20
12/01
06:43
12/01/20
06:43
LXRP

Lexaria Bioscience

$0.00 /

+ (+0.00%)

Lexaria Bioscience…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LXRP Lexaria Bioscience
$0.00 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.